BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37922631)

  • 1. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
    Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
    Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
    Leroy R; Silversmit G; Stordeur S; De Gendt C; Verleye L; Schillemans V; Savoye I; Van Eycken L; Deron P; Hamoir M; Vermorken J; Grégoire V; Nuyts S
    Eur J Cancer; 2020 May; 130():81-91. PubMed ID: 32179449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients.
    Bourgeois J; Peacock HM; Savoye I; De Gendt C; Leroy R; Silversmit G; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
    Eur J Surg Oncol; 2024 Mar; 50(3):107978. PubMed ID: 38306864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
    Bristow RE; Palis BE; Chi DS; Cliby WA
    Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Population-Based Study Using Belgian Cancer Registry Data Supports Centralization of Esophageal Cancer Surgery in Belgium.
    van Walle L; Silversmit G; Depypere L; Nafteux P; Van Veer H; Van Daele E; Deswysen Y; Xicluna J; Debucquoy A; Van Eycken L; Haustermans K;
    Ann Surg Oncol; 2023 Mar; 30(3):1545-1553. PubMed ID: 36572806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
    Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
    Timmermans M; Schuurman MS; Ho VKY; Massuger LF; Nijman HW; van Gorp T; Sonke GS; Kruitwagen RFPM; van der Aa MA
    Gynecol Oncol; 2018 Jan; 148(1):56-61. PubMed ID: 29129391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
    Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
    Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
    Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
    BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
    Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic status and epithelial ovarian cancer survival in Sweden.
    Weiderpass E; Oh JK; Algeri S; Bellocco R
    Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data.
    Wieser S; Schmidt M; Kind AB; Heinzelmann-Schwarz VA
    Swiss Med Wkly; 2018 Jul; 148():w14647. PubMed ID: 30141520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
    Lawal AO; Musekiwa A; Grobler L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
    Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
    Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
    Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based study.
    Schillemans V; Vrijens F; De Gendt C; Robays J; Silversmit G; Verleye L; Camberlin C; Dubois C; Stordeur S; Wauters I; Van Meerbeeck JP; Van Eycken E; De Leyn P
    Eur J Surg Oncol; 2019 Dec; 45(12):2443-2450. PubMed ID: 31153767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and Surgical Approach among Women with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.
    Persenaire C; Pyrzak A; Barber EL
    J Minim Invasive Gynecol; 2022 Mar; 29(3):375-384. PubMed ID: 34648931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hospital volume on processes of care and 5-year survival after breast cancer: a population-based study on 25000 women.
    Vrijens F; Stordeur S; Beirens K; Devriese S; Van Eycken E; Vlayen J
    Breast; 2012 Jun; 21(3):261-6. PubMed ID: 22204930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.